SGA
LEGN icon

Sector Gamma AS’s Legend Biotech LEGN Stock Holding History

Sector Gamma AS’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-48,495
Closed -$1.58M – 34
2024
Q4 		$1.58M Buy
48,495
+9,733
+25% +$403K 0.54% 30
2024
Q3 		$1.89M Buy
+38,762
New +$2.06M 0.57% 29

Other funds holding LEGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Sector Gamma AS's LEGN Position: Q1 2025 in Review

Sector Gamma AS sold out of Legend Biotech (LEGN) in Q1 2025, closing a stake of 48,495 shares — an estimated $1.58M sold.

Sector Gamma AS first reported a position in LEGN in Q3 2024 and held it in 2 quarters. The position peaked at $1.89M in Q3 2024. 208 funds tracked by Wall St. Rank hold LEGN as of Q1 2025.

  • Sector Gamma AS reported no remaining Legend Biotech position as of Q1 2025 after selling out during the quarter.
  • Sector Gamma AS sold 48,495 Legend Biotech shares in Q1 2025, an estimated $1.58M.
  • Sector Gamma AS first reported a position in Legend Biotech in Q3 2024 and held it in 2 quarters.
  • Sector Gamma AS's Legend Biotech position peaked at $1.89M in Q3 2024.
  • 208 funds tracked by Wall St. Rank held Legend Biotech as of Q1 2025.

Based on Sector Gamma AS's 13F filing for Q1 2025, filed 13 May 2025.